Evidence map›Paper›PMID 33920964›Full record

ArticleInternational journal of molecular sciences2021

Development of a Topical Insulin Polymeric Nanoformulation for Skin Burn Regeneration: An Experimental Approach.

Maria Quitério, Sandra Simões, Andreia Ascenso, Manuela Carvalheiro, Ana Paula Leandro, Isabel Correia, Ana Silveira Viana, Pedro Faísca, Lia Ascensão, Jesús Molpeceres and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. PluronicGels (Basel, Switzerland) · 2023
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Maria QuitérioiMed., ULisboa, Research Institute for Medicines, Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisboa, Portugal.ORCID 0000-0002-7045-1873
Sandra SimõesiMed., ULisboa, Research Institute for Medicines, Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisboa, Portugal.
Andreia AscensoiMed., ULisboa, Research Institute for Medicines, Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisboa, Portugal.
Manuela CarvalheiroiMed., ULisboa, Research Institute for Medicines, Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisboa, Portugal.ORCID 0000-0002-6028-4717
Ana Paula LeandroiMed., ULisboa, Research Institute for Medicines, Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisboa, Portugal.ORCID 0000-0002-2946-9342
Isabel CorreiaCentro de Química Estrutural, Instituto Superior Técnico, Departamento de Engenharia Química, Universidade de Lisboa, 1049-001 Lisboa, Portugal.ORCID 0000-0001-7096-4284
Ana Silveira VianaCentro de Química Estrutural, Faculdade de Ciências, Universidade de Lisboa, 1749-016 Lisboa, Portugal.ORCID 0000-0001-8405-9672
Pedro FaíscaFaculdade de Medicina Veterinária, Universidade Lusófona de Humanidades e Tecnologias, 1794-024 Lisboa, Portugal.ORCID 0000-0002-3922-3602
Lia AscensãoCentro de Estudos do Ambiente e do Mar (CESAM), Faculdade de Ciências, Universidade de Lisboa, 1749-016 Lisboa, Portugal.ORCID 0000-0001-7439-5912
Jesús MolpeceresDepartment of Biomedical Sciences, Faculty of Pharmacy, University of Alcalá, Campus Universitario, 28871 Alcalá de Henares, Spain.
Maria Manuela GaspariMed., ULisboa, Research Institute for Medicines, Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisboa, Portugal.
Catarina Pinto ReisiMed., ULisboa, Research Institute for Medicines, Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisboa, Portugal.ORCID 0000-0002-1046-4031
University of Lisbon · PTUniversidad de Alcalá · ESUniversidade Lusófona · PT

Funding

FCT IF/00841/2012FCT UIDB/04138/2020FCT UIDP/04138/2020 and UIDB/0100/2020Young Investigator Award 2018 (iMed.Ulisboa) 2018
6 · The paper itself

Abstract

Insulin is a peptide hormone with many physiological functions, besides its use in diabetes treatment. An important role of insulin is related to the wound healing process-however, insulin itself is too sensitive to the external environment requiring the protective of a nanocarrier. Polymer-based nanoparticles can protect, deliver, and retain the protein in the target area. This study aims to produce and characterize a topical treatment for wound healing consisting of insulin-loaded poly-DL-lactide/glycolide (PLGA) nanoparticles. Insulin-loaded nanoparticles present a mean size of approximately 500 nm and neutral surface charge. Spherical shaped nanoparticles are observed by scanning electron microscopy and confirmed by atomic force microscopy. SDS-PAGE and circular dichroism analysis demonstrated that insulin preserved its integrity and secondary structure after the encapsulation process. In vitro release studies suggested a controlled release profile. Safety of the formulation was confirmed using cell lines, and cell viability was concentration and time-dependent. Preliminary safety in vivo assays also revealed promising results.

Indexed as

Drug CompoundingRegenerationAdministration, TopicalAnimalsBurnsCell SurvivalCircular DichroismDrug LiberationFemaleHaCaT CellsHumansInsulinMiceNanoparticlesParticle SizePolylactic Acid-Polyglycolic Acid CopolymerInsulinPolylactic Acid-Polyglycolic Acid CopolymerinsulinnanoparticlesPLGAtopical administrationwound healing

Identifiers

PMID33920964
PMCPMC8071315
OpenAlexW3155582627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.